A new drug called baxdrostat shows transformative potential for treating a common but under-diagnosed cause of high blood pressure by significantly lowering blood pressure and normalizing key hormone levels.
Most Recent Articles
Successful Use of Ruxolitinib in a Case of Acute Fulminant Myocarditis
UC San Francisco researchers report a breakthrough case where a JAK inhibitor successfully treated a patient with life-threatening acute fulminant myocarditis, a severe form of heart inflammation.
The Estrogen-ANXA1 Axis: A Key Regulator of Cardiovascular Remodeling in Female Hypertension
A new study reveals how the female hormone estrogen protects the heart from damage caused by high blood pressure through a protein called ANXA1, paving the way for sex-specific treatments.
VISUALIZED: Catheter vs. Surgical Ablation for AF: A Review of Clinical Outcomes
Read further: Catheter vs. Surgical Ablation for AF: A Review of Clinical Outcomes
RAG Enhances Local LLM Performance for Radiology Contrast Media Consultations
A new study reveals how retrieval-augmented generation (RAG) can create safer, faster, and more private AI for clinical decision-making, eliminating dangerous hallucinations in simulated radiology consultations.
